Sherry McKee, PhD

Professor of Psychiatry; Director, Yale Behavioral Pharmacology Laboratory; Clinical Director, FORDD Addiction Clinic; Deputy Director, Women's Health Research at Yale

Patient Care

Accepts new patients? No
Patient Type:
Referrals: Not Applicable

Patient Care Organizations

Psychiatry: Connecticut Mental Health Center: Division of Substance Abuse | Law and Psychiatry, Division of | Psychology Section | Stress & Addiction Clinical Research Program

Clinical Trials

Conditions Study Title
Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation
Modeling Stress-precipitated Smoking Behavior for Medication Development: Guanfacine
Does Guanfacine, an alpha2 adrenergic agonist, attenuate stress-induced drinking?
Test-retest reproducibility of (11 C) PHNO PET using the constant infusion paradigm
Does Doxazosin Attenuate Stress-induced Smoking and Improve Clinical Outcomes?
MRI Studies of Emotion, Addiction and Impulse Control Disorders
Imaging extrastriatal dopamine release in tobacco smokers and nonsmokers

Edit this profile

Contact Info

Sherry McKee, PhD
Mailing Address
Yale Behavioral Pharmacology Laboratory2 Church St. South, #109
New Haven, CT 06519

Yale Behavioral Pharmacology Laboratory

Yale Tobacco Treatment Clinic: A Clinical Research Program

Yale Translational Center for Gender-Sensitive Medication Development for Tobacco Dependence